ABOUT US

We are a forward-thinking, mid-size contract research organization, offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development including preclinical safety testing, clinical pharmacology, bioanalysis and research services. Focused on your success … always available and always looking ahead. Moving in unison to deliver big impact with a personal touch.

More About Us

The devotion, expertise, and degree of professionalism employed by the (Altasciences) team in all stages of development, and the support provided during the Clinical trial, were unprecedented.

Joanna L Gore, Ph.D., Clinical Research Scientist, Drug Development
Jamie L Doran, MSc, DABT, ERT, VP Drug Development Appili Therapeutics Inc.

RESOURCE CENTER

Feb 2020 Altasciences Blog - Making the Most of Your CRO Partnership

Read the Blog

Making the Most of your CRO Partnership

February 20, 2020

Choosing the right CRO as a partner for your drug development programs is a vitally important step to achieving critical decision making early on for important milestones, and ultimately getting your molecule from discovery to market efficiently.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Careers

Join our team! Work at Altasciences - View all clinical job postings

Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.

Learn More

NEWS & EVENTS

Altasciences Completes Phase I Study on Gimsilumab for ARDS in COVID-19

Related Press Release

Altasciences Completes Phase I Study on Gimsilumab for ARDS in COVID-19

Mar 27, 2020

Altasciences has completed a Phase I study for the development of gimsilumab, a fully human monoclonal antibody that targets granulocyte-macrophage colony stimulating factor (GM-CSF), found to be up-regulated in SARS CoV-2 in patients with or at risk of developing acute respiratory distress syndrome (ARDS).

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Our Solutions

TESTIMONIALS

Find out what companies around the world are saying about working with Altasciences.

Chondrial logo

Re: IND-enabling bioanalytical support provided by Altasciences

We were very pleased with the way the team at Altasciences negotiated the…

Appili Therapeutics Logo

RE: Testimonial: Mitra® work provided by Altasciences…

Tetra Bio Pharma

Re: Altasciences [Double-Blind Phase I Study to Assess Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of cannabinoids by Inhalation…

Locemia Solutions Logo

We have retained the services of Algorithme Pharma (now Altasciences) since 2011 to perform a series of studies ranging from Phase I to Phase III…

gIcare pharma inc logo

Algorithme Pharma (now Altasciences) has been a great partner for us, in the context of key clinical trials for our lead drug candidates. The…

IDENIX logo

I am writing to recommend the services of Algorithme Pharma (now Altasciences). I have been using Algorithme Pharma (now Altasciences)…

Ethypharm logo

Algorithme Pharma (now Altasciences) has been a great partner of ours over the years, in performing Phase I studies in healthy volunteers.…

Isis Ionis Pharmaceuticals Logo

I am writing to recommend the services of Algorithme Pharma (now Altasciences), with whom Isis Pharmaceuticals Inc. (now Ionis) have partnered to…

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.

Working as a flexible, attentive extension of your team, we offer all you need to move your molecule forward.

Let's Get Started

STAY CONNECTED

2019 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy